Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab
Clinical trial NCT05188495 · UNKNOWN
Trial details
- NCT number
- NCT05188495
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-10
- Primary completion
- 2023-12-10
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.